• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC
Click for more information
4.17% 37.5¢

RACE ONCOLOGY LTD

Market Cap $39.29M  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
RAC Charts
11 12 13
13:05 779 143K
13:05 Last post  Rossi70 Comments Created with Sketch.  779  Views Created with Sketch.  143K 
RAC
Ann: Race significantly strengthens Clinical Advisory Board 		11:27 6 748
11:27 Last post  johndprent Comments Created with Sketch.  6  Views Created with Sketch.  748 
RAC
General Comments / Chat
2
08:03 95 17K
08:03 Last post  RaceOncology Comments Created with Sketch.  95  Views Created with Sketch.  17K 
RAC
Negatives 		19/02/20 30 5.3K
19/02/20 Last post  JaneD2010 Comments Created with Sketch.  30  Views Created with Sketch.  5.3K 
RAC
Ann: Appendix 3G 		18/02/20 13 2.5K
18/02/20 Last post  Xfarmer Comments Created with Sketch.  13  Views Created with Sketch.  2.5K 
RAC
Ann: Race appoints Australian Clinical Program Director 		17/02/20 8 1.3K
17/02/20 Last post  RaceOncology Comments Created with Sketch.  8  Views Created with Sketch.  1.3K 
RAC
Responsibilities of the team
2
17/02/20 104 16K
17/02/20 Last post  Aqua65 Comments Created with Sketch.  104  Views Created with Sketch.  16K 
RAC
Introductions 		15/02/20 20 3.2K
15/02/20 Last post  EddyG Comments Created with Sketch.  20  Views Created with Sketch.  3.2K 
RAC
Ann: Australian Clinical Trials Manager to replace European Role 		10/02/20 19 3.4K
10/02/20 Last post  johndprent Comments Created with Sketch.  19  Views Created with Sketch.  3.4K 
RAC
Periodic FA Thread - RACE Oncology
2
09/02/20 113 18K
09/02/20 Last post  RaceOncology Comments Created with Sketch.  113  Views Created with Sketch.  18K 
RAC
Progress of Israel R/R AML trial 		07/02/20 13 2.1K
07/02/20 Last post  EddyG Comments Created with Sketch.  13  Views Created with Sketch.  2.1K 
RAC
Medical / Clinical Discussions 		06/02/20 5 668
06/02/20 Last post  Titans19 Comments Created with Sketch.  5  Views Created with Sketch.  668 
RAC
Ann: Appendix 3X-Prof Borje Andersson 		03/02/20 0 260
03/02/20 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  260 
RAC
To trial Bisantrene on various cancers 		01/02/20 2 413
01/02/20 Last post  RaceOncology Comments Created with Sketch.  2  Views Created with Sketch.  413 
RAC
Ann: December 2019 Quarterly Report 		30/01/20 5 948
30/01/20 Last post  RaceOncology Comments Created with Sketch.  5  Views Created with Sketch.  948 
RAC
Ann: Prof Borje Andersson appointed as Non-Executive Director 		28/01/20 8 1.5K
28/01/20 Last post  Titans19 Comments Created with Sketch.  8  Views Created with Sketch.  1.5K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Race significantly strengthens Clinical Advisory Board
20 Feb 09:39
 
Appendix 3G
17 Feb 15:21
 
Race appoints Australian Clinical Program Director
17 Feb 13:19
 
Appendix 3X-Prof Borje Andersson
03 Feb 14:56
 
December 2019 Quarterly Report
30 Jan 09:45
 
Appendix 3B
28 Jan 11:23
 
View More arrow Created with Sketch.
(20min delay)
Trade with IG Advertisement
Last
37.5¢ 		Change
0.015(4.17%) 		Mkt cap ! $39.29M
Open High Low Value Volume
36.0¢ 38.5¢ 36.0¢ $76.38K 202.1K

Buyers (Bids)

No. Vol. Price($)
1 895 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 69588 2
View Market Depth
Last trade - 12.42pm 20/02/2020 (20 minute delay) ?
(live)
Last
37.5¢ 		  Change
0.015 ( 6.02 %)
Open High Low Volume
35.5¢ 38.0¢ 35.5¢ 51585
Last updated 14.11pm 20/02/2020 (live) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.